Weekly administration on the same day helps maintain stable therapeutic levels and reinforces the habit of regular dosing
Because pill-based GLP-1 options are easier to initiate, providers may consider them sooner in the disease progression
However, all decisions must involve your bariatric surgeon, primary care physician, and ideally an endocrinologist familiar with both surgical and medical weight loss approaches
Your provider may also assess lifestyle habits, metabolic health markers, and overall well-being to ensure your program stays effective and personalized.
Diabetologia 53:153159 Nyborg NC, Molck AM, Madsen LW, Knudsen LB (2012) The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species